Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: Polymorphisms of CCR5

Nephrology Dialysis Transplantation

Volumn 24, Issue 9, 2009, Pages 2919-2925

  Cha, Ran Hui ^a   Yang, Seung Hee ^a   Kim, Hyo Sang ^a   Kim, Sun Moon ^a   Park, Myoung Hee ^a   Ha, Jongwon ^a   Kim, Yon Su ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Acute rejection; CCR5; Kidney transplantation; Polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ACUTE GRAFT REJECTION; ADULT; ALLELE; AMPLICON; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENETIC VARIABILITY; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; ALLELES; BASE SEQUENCE; CREATININE; DNA PRIMERS; FEMALE; GENE FREQUENCY; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR5; SEQUENCE DELETION; TIME FACTORS; TISSUE DONORS; YOUNG ADULT;

EID: 69249136994     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp317     Document Type: Article

References (28)

1. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006; 81: 643-654
2. Abul KA, Andrew HL, Shiv P. Cellular and Molecular Immunology, 6th edn. Philadelphia, PA: Saunders Elsevier, 2005, 375-396
3. Hancock WW, GaoW, Faia KL et al. Chemokines and their receptors in allograft rejection. Curr Opin Immunol 2000; 12: 511-516
4. Keen LJ. The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transpl Immunol 2002; 10: 143-146
5. Lacha H, Hribova P, Kotsch K et al. Effect of cytokines and chemokines (TGF-beta, TNF-alpha, IL-6, IL-10, MCP-1, RANTES) gene polymorphisms in kidney recipients on posttransplantation outcome: influence of donor-recipientmatch. Transplant Proc. 2005; 37: 764-766
6. Marin LA, Muro M, Moya-Quiles MR et al. Study of Fas(CD95) and FasL(CD178) polymorphisms in liver transplant recipients. Tissue Antigens 2006; 67: 117-126
7. Hancock WW, Gao W, Csizmadia V et al. Donor-derived IP-10 initiates development of acute allograft rejection. J ExpMed 2001; 193: 975-980
8. Nakajima K, Tanaka Y, Nomiyama T et al. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care 2003; 26: 892-898
9. Clark VJ, Dean M. Haplotype structure and linkage disequilibrium in chemokine and chemokine receptor genes. Hum Genomics 2004; 1: 255-273
10. Naruse K, Ueno M, Satoh T et al. A YAC contig of the human CC chemokine genes clustered on chromosome 17q11.2. Genomics 1996; 34: 236-240
11. Fernandez-Mestre MT, Montagnani S, Layrisse Z. Is the CCR5-59029-G/G genotype a protective factor for cardiomyopathy inChagas disease? Hum Immunol 2004; 65: 725-728
12. Ahn SH, Kim DY, Chang HY et al. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. J Med Virol 2006; 78: 1564-1571
13. Simeoni E, Vassalli G, Seydoux C et al. CCR5, RANTES and CX3CR1 polymorphisms: possible genetic links with acute heart rejection. Transplantation 2005; 80: 1309-1316
14. Schr̈oppel B, Fischereder M, Lin M et al. Analysis of gene polymorphisms in the regulatory region of MCP-1, RANTES, and CC5 in liver transplant recipients. J Clin Immunol 2002; 22: 381-385
15. Ruster M, Sperschneider H, Funfstuck R et al. Differential expression of beta chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. Clin Nephrol 2004; 61: 30-39
16. El-sawy T, Fahmy NM, Fairchild RL. Chemokines: directing leukocyte infiltration into allografts. Curr Opin Immunol 2002; 14: 562-568
17. Inston NG, Cockwell P. The evolving role of chemokines and their receptors in acute allograft rejection Nephrol Dial Transplant 2002; 17: 1374-1379
18. Schlondorff D, Nelson PJ, Luckow B et al. Chemokines and renal disease. Kidney Int 1997; 51: 610-621
19. Hoffmann S, Park J, Jacobson LM et al. Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int 2004; 66: 1686-1693
20. Yigit B, Bozkurt N, Berber I et al. Analysis of CC chemokine receptor 5 and 2 polymorphisms and renal transplant survival. Cell Biochem Funct 2007; 25: 423-426
21. Abdi R, Huong TTB, Sahagun-RuizAet al. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 2002; 13: 754-758
22. Gr̈one HJ, Weber C, Kim SC et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J 1999; 13: 1371-1383
23. Fischereder M, Luckow B, Hocher B et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 2001; 23: 1758-1761
24. Takacova M, Nogova P, Habekova M et al. Prevalence of a 32bp deletion in the gene for human immunodeficiency virus 1 co-receptor ccr5 in Slovak population. Acta Virol 2008; 52: 261-264
25. Thio CL, Astemborski J, Thomas R et al. Interaction between RANTES promoter variant and CCR5Δ32 favors recovery from hepatitis B. J Immunol 2008; 181: 7944-7947
26. Wang F, Xiul MH, Zhou DF et al. The CCR5 32-bp deletion allele is rare in a Chinese population. Schizophr Res 2008; 101: 341-343
27. Prahalad S, Bohnsack JF, Jorde LB et al.Association of two functional polymorphism in the CCR5 gene with juvenile rheumatoid arthritis. Genes Immun 2006; 7: 468-475
28. Berce V, Repnik K, Potocnik U. Association of CCR5-delta32 mutation with reduced risk of nonatopic asthma in Slovenian children. J Asthma 2008; 45: 780-784